Loading clinical trials...
Loading clinical trials...
Study GIPF-004 is an open-label, multicenter study that will enroll approximately 250 patients who complete Protocol GIPF-001. The purpose of this study is to assess the safety and efficacy of continu...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
InterMune
NCT07647575 · Nontuberculous Mycobacterial Lung Disease, Bronchiectasis
NCT07516379 · Lung Transplant, End Stage Lung Disease, and more
NCT07489066 · Carcinoma, Non-Small-Cell Lung, and more
NCT07615504 · Interstitial Lung Disease (ILD)
NCT05842681 · Idiopathic Pulmonary Fibrosis
University of Washington Medical Center
Seattle, Washington
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions